MétaCan
Menu
Back to cohort
Record W4291002222 · doi:10.51731/cjht.2022.414

An Overview of Comprehensive Genomic Profiling Technologies to Inform Cancer Care

2022· article· en· W4291002222 on OpenAlex
Sinwan Basharat, Kelly Farah

Why this work is in the frame

A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.

aboutThe title or abstract carries a Canadian signal from the geographic lexicon.
no affNo Canadian affiliation: this work is invisible to an affiliation-only frame.
No Canadian affiliation. An affiliation-only frame, the usual design, would never have seen this work. It is one of the works that make the case for inverting the frame.

Bibliographic record

VenueCanadian Journal of Health Technologies · 2022
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicCancer Genomics and Diagnostics
Canadian institutionsnot available
Fundersnot available
KeywordsProfiling (computer programming)Emerging technologiesClinical trialHealth careMedicineData scienceComputer sciencePathologyPolitical science

Abstract

fetched live from OpenAlex

Horizon Scan reports provide brief summaries of information regarding new and emerging health technologies; Heath Technology Update articles typically focus on a single device or intervention. This Horizon Scan summarizes the available information regarding emerging comprehensive genomic profiling (CGP) technologies for informing cancer treatments. These technologies are based on next-generation sequencing platforms, which can characterize up to hundreds of genes and other genomic information with a single sample. Emerging tests are also compatible with minimally invasive liquid biopsies that use fluids such as blood samples to support clinical decision-making. CGP could be an alternative or a complement to conventional testing that uses single-biomarker assays or limited gene panels. Some emerging CGP tests available in Canada, the US, and Europe are being considered to inform the treatment of non–small cell lung cancer (NSCLC) because it has the highest number of identified biomarkers. Most identified studies have examined CGP use with NSCLC. The emerging evidence about the clinical and cost-effectiveness of CGP technologies for either NSCLC or other cancer types remains uncertain. Without randomized trials and robust study designs, it is not yet well-established whether the additional costs and technical requirements of CGP may provide better clinical outcomes compared with conventional molecular testing. This Horizon Scan also provides considerations for health systems about testing infrastructure, training for health care professionals, and understanding different patients’ perspectives should CGP or other next-generation sequencing technologies become more widely used in Canada.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Other design · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.887
Threshold uncertainty score0.597

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0010.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.045
GPT teacher head0.333
Teacher spread0.288 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it